UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20509
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
November 13, 2018
Date of Report
(Date of earliest event reported)
FUTURE HEALTHCARE OF AMERICA
(Exact name of registrant as specified in its charter)
| WYOMING | 000-54917 | 45-5547692 |
| (State or other jurisdiction of incorporation or organization) | Commission File Number | (I.R.S. Employer Identification No.) |
Jachthavenweg 124
1081 KJ Amsterdam
The Netherlands
(Address of principal executive offices)
011-31-68-333-1940
Registrant's telephone number
N/A
Former name or former address, if changed since last report
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 8.01. Other Events.
Future Healthcare of America announces that it has completed its share exchange transaction with Natur Holding B.V. See Exhibit 99.1.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits.
Description
Announcement of Completion of Share Exchange*
* filed herewith
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
| FUTURE HEALTHCARE OF AMERICA, |
| |
|
|
| a Wyoming corporation |
| |
|
|
|
|
|
|
|
|
|
|
|
|
| Dated: November 15, 2018 |
| By: | /S/ Ellen Berkers |
|
|
|
| Ellen Berkers, CEO |
| |